Media Summary: This presentation demonstrated creating a listing SPL through SBIA, in collaboration with the Drug Registration and Listing Branch (DRLB) in the Office of Compliance (OC), hosted its annual ... This annual event will provide: A demonstration on how-to submit establishment registration and drug listing data using

Edrls 2024 D1s05 1 Cder - Detailed Analysis & Overview

This presentation demonstrated creating a listing SPL through SBIA, in collaboration with the Drug Registration and Listing Branch (DRLB) in the Office of Compliance (OC), hosted its annual ... This annual event will provide: A demonstration on how-to submit establishment registration and drug listing data using This presentation provided comprehensive guidance on This presentation described drug listing requirements under 21 CFR 207 and identified common listing issues encountered during ... Learn directly from the FDA's regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed ...

This presentation described establishment registration requirements under 21 CFR 207 and identified common ... This presentation demonstrated drug listing update and listing certification requirements, describing what information must be ...

Photo Gallery

eDRLS 2024 | D1S05-1 - CDER Direct Drug Listing
REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 1
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024
FDA-NIH 2024 | D1S05 - Overview of CDER Nonclinical Resources and Guidance for Approaching First...
eDRLS 2024 | D1S05-4 - Complying with Drug Listing Requirements
eDRLS 2024 | D1S02-1 - CDER Direct Establishment Registration Demo
eDRLS 2024 | D1S03-1 - CDER Direct Labeler Code Request Demo
REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2)
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 2
eDRLS 2024 | D1S02-3 - Complying with Establishment Registration Requirements
EDRLS 2024 | D1S01 - Public Health Impact of Registration and Listing Data
View Detailed Profile
eDRLS 2024 | D1S05-1 - CDER Direct Drug Listing

eDRLS 2024 | D1S05-1 - CDER Direct Drug Listing

This presentation demonstrated creating a listing SPL through

REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)

REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)

This presentation introduced

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 1

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 1

SBIA, in collaboration with the Drug Registration and Listing Branch (DRLB) in the Office of Compliance (OC), hosted its annual ...

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024

This annual event will provide: A demonstration on how-to submit establishment registration and drug listing data using

FDA-NIH 2024 | D1S05 - Overview of CDER Nonclinical Resources and Guidance for Approaching First...

FDA-NIH 2024 | D1S05 - Overview of CDER Nonclinical Resources and Guidance for Approaching First...

This presentation provided comprehensive guidance on

eDRLS 2024 | D1S05-4 - Complying with Drug Listing Requirements

eDRLS 2024 | D1S05-4 - Complying with Drug Listing Requirements

This presentation described drug listing requirements under 21 CFR 207 and identified common listing issues encountered during ...

eDRLS 2024 | D1S02-1 - CDER Direct Establishment Registration Demo

eDRLS 2024 | D1S02-1 - CDER Direct Establishment Registration Demo

This presentation demonstrated

eDRLS 2024 | D1S03-1 - CDER Direct Labeler Code Request Demo

eDRLS 2024 | D1S03-1 - CDER Direct Labeler Code Request Demo

This presentation demonstrated the

REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2)

REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2)

Learn directly from the FDA's regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed ...

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 2

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct – 2024 – Part 2

SBIA, in collaboration with the Drug Registration and Listing Branch (DRLB) in the Office of Compliance (OC), hosted its annual ...

eDRLS 2024 | D1S02-3 - Complying with Establishment Registration Requirements

eDRLS 2024 | D1S02-3 - Complying with Establishment Registration Requirements

This presentation described establishment registration requirements under 21 CFR 207 and identified common ...

EDRLS 2024 | D1S01 - Public Health Impact of Registration and Listing Data

EDRLS 2024 | D1S01 - Public Health Impact of Registration and Listing Data

SBIA, in collaboration with the Drug Registration and Listing Branch (DRLB) in the Office of Compliance (OC), hosted its annual ...

eDRLS 2024 | D1S05-2 - Listing Updates and Blanket “No Changes” Certification Demo

eDRLS 2024 | D1S05-2 - Listing Updates and Blanket “No Changes” Certification Demo

This presentation demonstrated drug listing update and listing certification requirements, describing what information must be ...